Back to results
US 2022/0175791 A1Published application
Methods for Predicting Neisseria Spp. Susceptibility to Cefixime
AssigneeThe Regents of the University of California
InventorJeffrey D. Klausner
Life of this patent
Estimating the term…
Abstract
Disclosed herein are methods for assaying whether a given Neisseria species, such as a given Neisseria gonorrhoeae strain, is susceptible to a cefixime compound and treatment methods based on the assay results.
Claims14
A method for inhibiting the growth of a given Neisseria species, which comprises
- (A) determining the presence or absence of one or more amino acid alterations at amino acid positions 345, 375-377, 501, 542, and 551 in the penicillin-binding protein 2 (PBP2) of the given Neisseria species;
- (B) characterizing the given Neisseria species as being resistant to cefixime compounds where
- (1) one or more alterations at amino acid positions 345, 375-377, 501, 542, and 551 are present,
- (2) one or more amino acid alterations at amino acid positions 501, 542, and 551 are present, or
- (3) one or more amino acid alterations at amino acid positions 375-377 and one or more amino acid alterations at amino acid positions 312, 316, 512, and 545 are present;
- (C) characterizing the given Neisseria species as being susceptible to cefixime compounds where
- (1) amino acid alterations at amino acid positions 345, 375-377, 501, 542, and 551 are absent,
- (2) one or more amino acid alterations at amino acid positions 501, 542, and 551 are absent, and a combination of (a) one or more amino acid alterations at amino acid positions 375-377 and (b) one or more amino acid alterations at amino acid positions 312, 316, 512, and 545 is also absent,
- (3) amino acid alterations at amino acid positions 375-377, 501, 542, and 551 are absent,
- (4) amino acid alterations at amino acid positions 375-377 and 345 are absent,
- (5) amino acid alterations at amino acid positions 312, 316, 345, and 512 are absent,
- (6) amino acid alterations at amino acid positions 375-377 are present and amino acid alterations at amino acid positions 312, 316, 345, and 512 are absent, or
- (7) an amino acid alteration at amino acid position 345 is present and amino acid alterations at amino acid positions 501, 542, and 551 are absent;
- and
- (D) contacting the given Neisseria species with a cefixime compound where the given Neisseria species is characterized as being susceptible to cefixime compounds, and contacting the given Neisseria species with an antibacterial other than cefixime compounds where the given Neisseria species is characterized as being resistant to cefixime compounds.
12 more elements
A method for treating a subject for an infection by a given Neisseria species, which comprises
- (A) determining the presence or absence of one or more amino acid alterations at amino acid positions 345, 375-377, 501, 542, and 551 in the penicillin-binding protein 2 (PBP2) of the given Neisseria species;
- (B) characterizing the given Neisseria species as being resistant to cefixime compounds where
- (1) one or more alterations at amino acid positions 345, 375-377, 501, 542, and 551 are present,
- (2) one or more amino acid alterations at amino acid positions 501, 542, and 551 are present, or
- (3) one or more amino acid alterations at amino acid positions 375-377 and one or more amino acid alterations at amino acid positions 312, 316, 512, and 545 are present;
- (C) characterizing the given Neisseria species as being susceptible to cefixime compounds where
- (1) amino acid alterations at amino acid positions 345, 375-377, 501, 542, and 551 are absent,
- (2) one or more amino acid alterations at amino acid positions 501, 542, and 551 are absent, and a combination of (a) one or more amino acid alterations at amino acid positions 375-377 and (b) one or more amino acid alterations at amino acid positions 312, 316, 512, and 545 is also absent,
- (3) amino acid alterations at amino acid positions 375-377, 501, 542, and 551 are absent,
- (4) amino acid alterations at amino acid positions 375-377 and 345 are absent,
- (5) amino acid alterations at amino acid positions 312, 316, 345, and 512 are absent,
- (6) amino acid alterations at amino acid positions 375-377 are present and amino acid alterations at amino acid positions 312, 316, 345, and 512 are absent, or
- (7) an amino acid alteration at amino acid position 345 is present and amino acid alterations at amino acid positions 501, 542, and 551 are absent;
- and
- (D) administering to the subject a therapeutically effective amount of a cefixime compound where the given Neisseria species is characterized as being susceptible to cefixime compounds, and administering to the subject a therapeutically effective amount of an antibacterial that is not a cefixime compound where the given Neisseria species is characterized as being resistant to cefixime compounds.
12 more elements
4-5. (canceled)
(canceled)
Dependencies are inferred from the claim text.